10 Stocks Targeted By Short Sellers Recently
In this piece, we will take a look at ten stocks targeted by short sellers recently. For more stocks, head on over to 5 Stocks Targeted By Short Sellers Recently. A curious outcome of the turmoil ush...
Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, engages in developing various prescription drugs for severe pain relief in opioid misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection (TAAP) platform, an abuse-resistant opioid prodrug technology; and Multi-Pill Abuse Resistance (MPAR) platform, an over-dose protection opioid prodrug technology. The company is developing PF614, a TAAP oxycodone prodrug candidate for the treatment of acute or chronic pain; and PF614-MPAR, a combination product of PF614 and nafamostat for overdose protection against excessive oral ingestion, as well as an oral and inhalation drug product of nafamostat for use against coronaviral infections and other pulmonary diseases, such as cystic fibrosis. It is also developing PF614, an extended-release oxycodone-derivative that releases clinically effective oxycodone; PF329 for pain with abuse protection; PF8001 and PF8026 are extended and immediate-release prodrugs of amphetamine for ADHD; and PF9001 to treat Opioid use disorder. The company was founded in 2003 and is based in La Jolla, California.
0.4279 | |
0.4076 | |
- | |
0.4331 | |
0.4 | |
0.3711-2.15 | |
3 133 K | |
7 585 K | |
1 747 K | |
-0.55 | |
0.85 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
In this piece, we will take a look at ten stocks targeted by short sellers recently. For more stocks, head on over to 5 Stocks Targeted By Short Sellers Recently. A curious outcome of the turmoil ush...
In this piece, we will take a look at ten penny stocks with insider buying. For more penny stocks, head on over to 5 Penny Stocks with Insider Buying. With the first quarter of 2023 coming to an end,...
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: